# Competitive Evaluation — Imprivata (imprivata.com) vs. SignalGrid

> **What this is:** internal competitive research, compiled 2026-07-14 from public
> sources (every claim anchored to a real URL in Sources). imprivata.com and
> several trade pages return 403 to automated fetch, so content was read via
> search-result retrieval of those exact URLs. This doc makes no claims on
> SignalGrid's behalf — it exists to keep competitive risk low by naming the
> overlap precisely. **This is the hardest wall SignalGrid faces in healthcare;
> the analysis is deliberately unflattering where the overlap is real.**

## Executive summary

- **Threat is segment-dependent: HIGH in healthcare shared clinical devices; MEDIUM in retail/logistics/manufacturing; LOW-to-MEDIUM as a vendor-neutral decision overlay.** Imprivata is the entrenched incumbent for badge tap-in/tap-out, roaming sessions, and Seamless SSO on shared clinical devices — and it is actively building toward runtime risk decisioning, not standing still.
- **Most dangerous inconvenient truth: Imprivata already does per-action step-up on a high-risk workflow.** Confirm ID for EPCS enforces two-factor signing on *every* controlled-substance prescription — genuine per-transaction step-up, not just session tap-in. A meaningful slice of SignalGrid's "per-action step-up on workflow risk" is *already delivered* in healthcare's canonical high-risk action.
- **Imprivata has quietly acquired much of the "decision layer" story.** Its Nov-2025 acquisition of **Verosint** adds ~150 real-time risk signals and "block / challenge / step-up when risk is detected" automation being wired into access management and PAM. It also does **device posture checks** (OS, patch, config) and **conditional access**.
- **It even touches custody and the exact device classes SignalGrid targets.** Smart Docks / Mobile Device Access do "lock and log out on charge," device check-out/check-in accountability, and support **Zebra and Honeywell** shared devices. Imprivata now markets dedicated **manufacturing** and **transportation & logistics** solutions — so "Imprivata isn't in retail/logistics" is outdated.
- **A real, defensible seam still exists — but narrower than the SignalGrid thesis assumes:** a *vendor-neutral per-action Policy Decision Point that fuses physical **custody** (dock/charge/**tamper**) + badge-binding + **CIS/security-baseline** + posture + workflow risk into ONE allow/step-up/restrict/deny decision with a unified audit plane*, sitting **above** IAM/UEM/EDR/ITSM and even consuming Imprivata's badge as a signal. Imprivata owns the *pieces* but distributes them across a vertically integrated single-vendor stack, and its custody signals are used for session hygiene, not as fused inputs to a workflow-risk decision.

## What Imprivata is

The dominant **digital identity / access management vendor for healthcare** and other "mission- and life-critical" industries. Formerly NYSE-listed; taken private by **Thoma Bravo (2016, ~$544M)**, which still owns it; as of Feb 2026 Thoma Bravo engaged JPMorgan to explore a **sale**, with reporting citing **~$500M revenue**. Footprint: 45+ countries; press cites 500+ hospitals across 12 countries and ~1M healthcare users; ~47% of customers are healthcare. Flagship products **OneSign** (SSO/tap-and-go) and **Confirm ID** (step-up/EPCS) are unified under **Enterprise Access Management (EAM)**, now also packaged for financial services and other verticals. Recent M&A: **Verosint** (ITDR/risk signaling, Nov 2025).

## Overlap map (uncomfortable, healthcare)

| SignalGrid claim | Imprivata's overlapping capability |
|---|---|
| Badge binding to current holder on shared devices | OneSign Tap-and-Go / MDA: badge tap = authenticate; walk-away/tap-out instantly closes session |
| Attribution/audit "comes free" from the badge | Tap in/out on desktop + mobile, auto credential-clearing, auditable handoff |
| Roaming sessions across shared devices | Roaming workflows / session continuity across desktop and mobile |
| Extends identity to shared clinical workstations | Healthcare Seamless SSO extends Microsoft Entra to shared clinical workstations via badge tap |
| **Per-action step-up on workflow risk** | **Confirm ID / EPCS**: DEA-compliant two-factor on *every* controlled-substance prescription; step-up for other clinical/privileged workflows |
| Device posture in the decision | Device Posture Check / Conditional Access: OS, installed software, security config, patch levels |
| Physical custody (dock/charge) | Smart Docks + "lock and log out on charge"; device check-out/check-in accountability |
| Fuse risk signals into runtime step-up | Verosint: ~150 real-time signals; block/challenge/step-up on detected risk, embedded into EAM + PAM |

**Bottom line:** In healthcare shared clinical devices the overlap is severe. The "we already own the badge; attribution and audit come for free" objection is largely *valid*, and Imprivata further has per-transaction step-up (EPCS), posture checks, charge-state custody, and an in-flight risk-decisioning acquisition.

## Fundamental differences

| Dimension | Imprivata (EAM + Verosint + MDA/Smart Dock) | SignalGrid | Honest read |
|---|---|---|---|
| **Primary role** | Vertically integrated **badge-SSO + step-up stack** that *owns* the access flow (readers, appliances, agents) | **Overlay PDP** above IAM/UEM/EDR/ITSM, consumes existing signals (incl. Imprivata's badge) | Genuine architectural difference |
| **Per-action step-up** | Yes, but mostly **purpose-built** (EPCS mandated; select workflows); Verosint adds risk-triggered step-up | General, **configurable per-workflow** across arbitrary high-risk actions | Partly covered by Imprivata; SignalGrid's edge is generality + non-DEA workflows (thinner than "we invented per-action step-up") |
| **Signal fusion** | Distributed: badge (OneSign), posture (Conditional Access), charge-state (MDA), fraud risk (Verosint) — **not one fused verdict** | **Single fused verdict** across identity + posture + custody + badge + CIS baseline + workflow risk | Real differentiator: unification into one PDP + one audit plane |
| **Physical custody** | Charge/dock **detected for session hygiene** (logout on charge), check-in/out. No clear **tamper** signal or custody-as-decision-input | Custody (dock/charge/**tamper**) is a **first-class decision input** | Partial gap; Imprivata has adjacent pieces, not fused into workflow-risk; tamper unverified |
| **Security baseline** | Posture check (OS/patch/config) | Explicit **CIS-baseline alignment** | Nuance, not chasm |
| **Vendor neutrality** | Single-vendor; prefers Imprivata badge/readers/appliances | **Vendor-neutral**; treats Imprivata badge/session as one input | SignalGrid's cleanest structural difference |
| **Verticals** | Healthcare-deep (~47%); expanding to manufacturing, T&L, financial services | Cross-vertical from day one | Imprivata present outside healthcare but far shallower reference base |
| **Device classes** | Zebra, Honeywell, Apple, Spectralink (via MDA) | Same frontline classes | Overlap even on hardware; not a moat |

## Threat assessment (segment-specific)

- **Healthcare shared clinical devices — HIGH / near-wall.** Imprivata owns the badge, roaming session, Entra extension, per-transaction EPCS step-up, posture checks, charge-state custody, and is bolting on real-time risk decisioning (Verosint). **Do not attack badge-SSO or EPCS head-on here.** The residual seam is narrow but real: a **vendor-neutral, unified per-action decision + attribution plane fusing custody + baseline + badge + workflow risk across mixed multi-vendor fleets** — valuable to health systems with heterogeneous stacks, a need for one audit/decision layer above several vendors, or workflow-risk decisions outside Imprivata's DEA/clinical scope. **Sell *above* Imprivata, not against it.**
- **Retail / warehouse / logistics — MEDIUM (contestable, not green field).** The "Imprivata is absent" thesis is outdated — it markets Transportation & Logistics and Manufacturing solutions and supports Zebra/Honeywell. But its depth, references, and mindshare outside healthcare are thin, and its value prop there is still SSO/handoff, not custody-fused workflow-risk decisioning. **This is where SignalGrid can move fastest and win before Imprivata's non-healthcare motion matures.**
- **As a decision overlay generally — LOW-to-MEDIUM.** Imprivata's instinct is to own the stack, not be a neutral PDP consuming others' signals — room for a Switzerland-style overlay, provided SignalGrid resists being reframed as "a worse Imprivata."

**Do NOT compete head-on:** badge tap-in/tap-out on shared clinical workstations, EPCS/controlled-substance signing, Entra Seamless SSO. **Do compete:** cross-vertical frontline (retail/logistics/manufacturing), and a unified custody+baseline+workflow-risk decision/attribution layer above heterogeneous stacks.

## Differentiation & keep-risk-low recommendations

1. **Do not fight badge-SSO or EPCS.** Concede openly that Imprivata owns badge tap-in/out, roaming, Entra SSO, and per-transaction EPCS step-up. Position SignalGrid as a **layer above** that treats the Imprivata badge/session as a trusted *input*. This neutralizes "we already own the badge" by *agreeing* with it.
2. **Lead with unification + neutrality, not "per-action step-up."** Imprivata can already claim per-action step-up (EPCS) and risk step-up (Verosint). SignalGrid's honest, defensible claim is a **single vendor-neutral per-workflow verdict** fusing custody + CIS baseline + posture + badge + workflow risk into one decision **and one audit plane** across a mixed stack. Avoid overclaiming novelty on step-up itself.
3. **Anchor on custody-as-decision-input and tamper.** Imprivata uses charge/dock state for logout hygiene; SignalGrid should demonstrate custody (dock/charge/**tamper**) as a *gating signal in the verdict* — a framing Imprivata doesn't market. Validate that tamper detection is genuinely differentiated.
4. **Beachhead in retail/warehouse/logistics, and move quickly** — framed as "faster and deeper than Imprivata's emerging frontline motion," not "Imprivata isn't here." Zebra/Honeywell shared-scanner custody + workflow-risk decisioning is the lead use case where Imprivata's healthcare-shaped product is weakest.
5. **Prepare for the Verosint counter.** Track how Imprivata operationalizes Verosint's risk-based step-up. If it stays identity/fraud-signal-centric (credential stuffing, ATO, MFA fatigue) rather than device-custody/baseline-centric, that boundary is SignalGrid's durable differentiation. Message around *device/custody/baseline fusion* where Verosint is *identity/behavioral*.
6. **Be explicit internally about where Imprivata already wins** so sales doesn't walk into losing healthcare fights: badge-SSO, roaming, Entra extension, EPCS, and increasingly posture + risk step-up. Qualify healthcare deals for the *overlay/unification/mixed-fleet* pain, or lead with non-healthcare verticals.

**One-line verdict:** Imprivata is HIGH threat in healthcare shared clinical devices (an incumbent that already does badge attribution, per-transaction EPCS step-up, posture checks, charge-state custody, and is acquiring runtime risk-decisioning) and MEDIUM, contestable in retail/logistics (present but shallow). SignalGrid's honest, defensible position is a **vendor-neutral per-action decision/attribution overlay** that consumes Imprivata's badge as a signal and unifies custody + CIS baseline + posture + workflow risk — sold *above* Imprivata, led in non-healthcare verticals, never pitched as a badge-SSO replacement.

## Sources

pitchbook.com/profiles/company/51593-14 · biometricupdate.com/202602/thoma-bravo-taps-jpmorgan-to-sell-identity-authentication-firm-imprivata · thomabravo.com/behind-the-deal/how-imprivata-is-redefining-healthcare-security · en.wikipedia.org/wiki/Imprivata · imprivata.com/products/access-management/enterprise-access-management/single-sign-on · docs.imprivata.com/onesign/232/content/topics/onesign/sso/os365isxrunas.html (Healthcare Seamless SSO) · imprivata.com/knowledge-hub/tap-and-go · its.weill.cornell.edu/services/it-security-privacy/imprivata-tap-and-go · imprivata.com/products/access-management/mobile-device-access · imprivata.com/integrations/applications-supporting-mda (Zebra/Honeywell) · imprivata.com/resources/datasheets/imprivata-confirm-id-epcs · docs.imprivata.com/confirmid/content/topics/confirmid/home_epcs.html · docs.imprivata.com/onesign/242/content/topics/confirmid/administration/confirmidauthmethods.html · imprivata.com/DEA-FAQ · imprivata.com/knowledge-hub/device-posture-check · imprivata.com/knowledge-hub/conditional-access · imprivata.com/knowledge-hub/smart-dock · imprivata.com/knowledge-hub/device-check-out · docs.imprivata.com/mda/content/topics/releasenotes/mda_rn.html (lock/log out on charge) · imprivata.com/solutions/access-shared-devices-and-kiosks · globenewswire.com/news-release/2025/10/14/3166275/…/Imprivata-Acquires-Verosint… · biometricupdate.com/202511/imprivata-acquires-verosint… · imprivata.com/solutions/industries/for-manufacturing · imprivata.com/solutions/industries/for-transportation-and-logistics · imprivata.com/solutions/digital-identity · imprivata.com/resources/datasheets/imprivata-eam-for-financial-services · enlyft.com/tech/products/imprivata · globenewswire.com/news-release/2025/07/29/…/New-Imprivata-Report-Hospitals-Save… 

**Caveats:** imprivata.com and several trade pages 403 to direct fetch — content read via search-result retrieval of the exact URLs. Revenue (~$500M) is from sale-process reporting; a getLatka $130M figure appears stale and is not relied upon. Verosint integration into runtime step-up is recent (Nov 2025) and still being operationalized.
